Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
Cancer|October 1, 1993
TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancerF Guadagni, M Roselli, M Cosimelli, et al.Cancer|December 1, 1991
Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal studyF Guadagni, M Roselli, T Amato, et al.Anticancer Research|July 1, 1996
Tumor markers as targets for selective diagnostic and therapeutic proceduresM Roselli, F Guadagni, O Buonomo, et al.Tumori|August 9, 2003
[Intraoperative radiolocalization of intraductal breast carcinoma: sentinel lymph node evaluation]O Buonomo, A V Granai, R Piccirillo, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1989
Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancerK Yokoyama, J A Carrasquillo, A E Chang, et al.Journal of the National Cancer Institute|July 18, 1990
In vivo tumor targeting of a recombinant single-chain antigen-binding proteinD Colcher, R Bird, M Roselli, et al.Critical Reviews in Oncology/Hematology|March 6, 2017
Biological and predictive role of ERCC1 polymorphisms in cancerV Formica, E Doldo, F R Antonetti, et al.Seminars in Surgical Oncology|November 26, 1998
Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentationM Roselli, O Buonomo, A Piazza, et al.Cancer Biomarkers : Section a of Disease Markers|September 5, 2009
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patientsV Formica, M C Massara, I Portarena, et al.Anticancer Research|October 23, 2009
Determinants of homocysteine levels in colorectal and breast cancer patientsP Ferroni, R Palmirotta, F Martini, et al.Pageof 12